Docto24 Europe

Operating

Converts EU audience into recurring clinical revenue.

Layer: Telemedicine
Market: Germany
Jurisdictions: Germany
Licensing: Telemed since 2025. Operating under proposed MedCanG amendments — transition to in-person initial consults expected 2026.

Patient-facing telemedicine platform delivering consultations and prescriptions for medical cannabis, ED, migraines, and sleep disorders. Live at docto24.de.

2025

Telemed since

Highlights

Patient telemedicine: medical cannabis, ED, migraines, and sleep disorders.
Adapting to MedCanG amendments — in-person initial consults expected 2026.

Role in the system

Layer 03 — Telemedicine. Converts the same owned EU audience into recurring clinical revenue from consultations and prescriptions.

Connects to

Herb Hype Marketing

Nexdoc

Visit docto24.de

More in Telemedicine

Docto24 South AfricaSouth Africa

Thailand Telemedicine PlatformThailand

MediaraSwitzerland

Operating financials, processing volume, prescriber counts, and entity registrations available under NDA. Data room index on request. info@nextleaf-group.com

Full licensing register →Engagement process →